Off-Label and Underground: The Hidden Risks of GLP-1 Drugs for weight loss episode artwork

EPISODE · May 21, 2026 · 11 MIN

Off-Label and Underground: The Hidden Risks of GLP-1 Drugs for weight loss

from The state of art of scientific research · host Addiction Science Lab

In this episode, we take a closer look at the shadow side of the GLP-1 revolution. While medications like Ozempic, Wegovy, and Mounjaro have transformed diabetes treatment, their meteoric rise as weight-loss solutions has opened a complex "underground" frontier.Together with Professor Lambros Lazuras, we investigate the drivers behind this shift—from social media hype to the cultural pressure for rapid results. We explore the clinical and societal dangers of off-label use, the surge in non-prescription consumption, and the alarming emergence of sophisticated counterfeit products. This conversation offers a critical look at how pharmaceutical innovation, when detached from medical supervision, poses new and significant risks to global public health.------------------------------------------------In questo episodio analizziamo il lato oscuro della rivoluzione GLP-1. Se da un lato farmaci come Ozempic, Wegovy e Mounjaro hanno trasformato la cura del diabete, la loro ascesa fulminea come soluzione per il dimagrimento rapido ha aperto una complessa frontiera "underground".Insieme al Professor Lambros Lazuras, indaghiamo le cause di questa trasformazione: dall'hype dei social media alla pressione culturale per risultati rapidi. Esploriamo i pericoli clinici e sociali dell'uso off-label, l'aumento dei consumi senza prescrizione e l'allarmante diffusione di prodotti contraffatti. Un dialogo critico su come l’innovazione farmaceutica, se slegata dalla supervisione medica, possa generare rischi nuovi per la salute pubblica globale.------------------------------------------------Interview with Professor Lambros Lazuras, PhD, Cpsychol - Professor of Psychology, Sport & Exercise Science - Director of Research & Knowledge Exchange - School of Psychology, Sport Science, & Wellbeing, University of Lincoln, UK.Interview by Dr. Gabriele Penazzi, PhD, Addiction Science Lab, Department of Psychology and Cognitive Sciences, University of Trento.Addiction Lab Podcasts curated by Professor Ornella Corazza, Director of Addiction Science Lab - Department of Psychology and Cognitive Science - University of Trento.Podcast Production, Music composition, Sound design by Leonidas Danezos. 

NOW PLAYING

Off-Label and Underground: The Hidden Risks of GLP-1 Drugs for weight loss

0:00 11:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The state of art of scientific research?

This episode is 11 minutes long.

When was this The state of art of scientific research episode published?

This episode was published on May 21, 2026.

What is this episode about?

In this episode, we take a closer look at the shadow side of the GLP-1 revolution. While medications like Ozempic, Wegovy, and Mounjaro have transformed diabetes treatment, their meteoric rise as weight-loss solutions has opened a complex...

Can I download this The state of art of scientific research episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!